Yiwei Ng

Yiwei Ng (Huang Yi Wei) currently serves as a Manager in Clinical Improvement within the Medical and Quality Clinical Governance division at IHH Healthcare, one of Asia’s largest private healthcare providers. In her role, she spearheads initiatives aimed at enhancing clinical quality, patient safety, and overall healthcare outcomes across the group’s extensive network of hospitals and clinics. Leveraging her robust background in pharmacy, public health, and healthcare management, Yiwei plays a pivotal role in developing and implementing evidence-based clinical protocols, risk management strategies, and quality improvement projects that align with international standards and regulatory requirements.

Her expertise in pharmacotherapy and pharmacology enables her to lead multidisciplinary teams in optimizing drug delivery processes and medication safety, reducing clinical risks, and fostering a culture of continuous improvement. Yiwei’s key projects often involve clinical research collaborations, data-driven performance analysis, and the integration of innovative healthcare technologies to streamline patient care pathways. Her deep understanding of healthcare management and pharmaceutical industry dynamics allows her to navigate complex clinical governance frameworks effectively.

With over a decade of experience, Yiwei’s strategic approach to clinical improvement emphasizes patient-centered care, safety, and operational efficiency. She actively collaborates with healthcare professionals, pharmacists, and administrative teams to implement best practices that elevate the quality of care delivered across IHH Healthcare’s facilities. Her leadership in risk management and clinical governance not only enhances patient outcomes but also reinforces the organization’s commitment to excellence in healthcare delivery.